ACTRN12617001478303
Recruiting
未知
A randomised, placebo controlled trial of N-acetylcysteine for cessation of tobacco smoking and 6-month post treatment abstinence in current smokers who are contemplating quitting
ConditionsTobacco Use Disorder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Tobacco Use Disorder
- Sponsor
- Barwon Health
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
The effect of N-acetylcysteine (NAC) in patients with moderate traumatic brain injury (MTBI)IRCT2017010131709N1Vice Chancellor for research of Arak University of Medical Sciences104
Recruiting
Phase 2
Treatment using N-acetyl cysteine (Injection) to reduce occurrence of muscle weakness and death in patients admitted with organophosphate (OP) pesticide poisoning.Health Condition 1: T600- Toxic effect of organophosphate and carbamate insecticidesCTRI/2020/09/028060Christian medical college Vellore
Completed
Phase 3
Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N55Bagheiat-allah University of Medical Sciences250
Completed
Not Applicable
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease.Chronic obstructive pulmonary diseaseRespiratoryPulmonary diseaseISRCTN21676344Health Research Council of New Zealand50
Completed
Phase 2
ortriptyline in knee arthritisACTRN12614000683639Dr Ben Hudson200